The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Chen Thomas F since year 2005.
The trader's CIK number is 1360147.
At the time of this reporting, Chen Thomas F is the Senior Vice President of Abbott Laboratories .
(stock ticker symbol ABT).
See this page for all insider trading activities at Abbott Laboratories .
Stock purchases, sales, and option exercises reported by insider Chen Thomas F since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-09-30
ABT
Abbott Laboratories
Option Exercise
1,620
45.45
73,627
2008-08-08
ABT
Abbott Laboratories
Sale
10,000
59.00
590,000
2008-07-09
ABT
Abbott Laboratories
Option Exercise
7,306
45.45
332,048
2008-06-02
ABT
Abbott Laboratories
Option Exercise
2,223
44.96
99,946
2008-05-29
ABT
Abbott Laboratories
Option Exercise
24,739
42.66
1,055,462
2008-02-08
ABT
Abbott Laboratories
Option Exercise
35,929
47.21
1,696,238
2008-02-08
ABT
Abbott Laboratories
Sale
35,929
56.76
2,039,150
2007-11-26
ABT
Abbott Laboratories
Sale
2,442
55.50
135,531
2007-11-20
ABT
Abbott Laboratories
Sale
10,000
55.50
555,000
2007-11-12
ABT
Abbott Laboratories
Sale
10,000
55.00
550,000
2007-11-07
ABT
Abbott Laboratories
Sale
7,400
54.50
403,300
2007-11-05
ABT
Abbott Laboratories
Sale
2,600
54.50
141,700
2007-09-19
ABT
Abbott Laboratories
Option Exercise
15,161
42.50
644,309
2007-08-07
ABT
Abbott Laboratories
Option Exercise
36,672
41.42
1,519,017
2007-08-08
ABT
Abbott Laboratories
Option Exercise
12,974
42.50
551,366
2007-05-16
ABT
Abbott Laboratories
Sale
8,000
59.25
474,008
2007-01-30
ABT
Abbott Laboratories
Option Exercise
49,458
41.71
2,063,044
2007-01-30
ABT
Abbott Laboratories
Sale
7,838
53.11
416,299
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Chen Thomas F
(Senior Vice President of Abbott Laboratories at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
